NO20053715L - 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk - Google Patents
10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykkInfo
- Publication number
- NO20053715L NO20053715L NO20053715A NO20053715A NO20053715L NO 20053715 L NO20053715 L NO 20053715L NO 20053715 A NO20053715 A NO 20053715A NO 20053715 A NO20053715 A NO 20053715A NO 20053715 L NO20053715 L NO 20053715L
- Authority
- NO
- Norway
- Prior art keywords
- dialkylprostanoic
- agents
- acid derivatives
- indicates
- glaucoma
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 230000004410 intraocular pressure Effects 0.000 title 1
- 208000010412 Glaucoma Diseases 0.000 abstract 2
- 206010030043 Ocular hypertension Diseases 0.000 abstract 2
- -1 or CO2R Chemical group 0.000 abstract 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000000520 N-substituted aminocarbonyl group Chemical group [*]NC(=O)* 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Foreliggende oppfinnelse tilveiebringer en fremgangsmåte for behandling av okulær hypertensjon eller glaukom, som omfatter å administrere til et dyr som har okulær hypertensjon eller glaukom en terapeutisk effektiv mengde av en forbindelse representert ved den generelle formel (I); hvor den stiplede linjen indikerer nærvær eller fravær av en binding, den skraverte kilen indikerer a- (ned) konfigurasjonen, og det fylte triangelet indikerer ß- (opp) konfigurasjonen; B er en enkel, dobbel eller trippel kovalent binding; n er 0-6; X er CH2, S eller O; Y er et hvilket som heist farmasøytisk akseptabelt salt av CO2H, eller CO2R, CONR2, CONHCH2CH2OH, CON(CH2CH2OH)2, CH2OR, P(O)(OR)2, CONRSO2R, SONR2, eller formel (la) R er H, C1-6-alkyl eller C2-6-alkenyl; R2 og R3 er lineært C1-6-alkyl som kan være like eller forskjellige, og kan være bundet til hverandre slik at de danner en ring som innlemmer karbonatomet som de i fellesskap er festet til.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/365,369 US6875787B2 (en) | 2003-02-11 | 2003-02-11 | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| US10/772,720 US20040235958A1 (en) | 2003-02-11 | 2004-02-04 | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| PCT/US2004/003433 WO2004071428A2 (en) | 2003-02-11 | 2004-02-06 | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20053715D0 NO20053715D0 (no) | 2005-08-01 |
| NO20053715L true NO20053715L (no) | 2005-10-27 |
| NO334659B1 NO334659B1 (no) | 2014-05-12 |
Family
ID=32871611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053715A NO334659B1 (no) | 2003-02-11 | 2005-08-01 | 10,10-dialkylprostanoinsyre-derivater, fremgangsmåte for fremstilling av slike, farmasøytisk produkt omfattende slike samt anvendelse av slike som midler for å senke intraokulært trykk |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1608309B1 (no) |
| JP (1) | JP5319065B2 (no) |
| KR (1) | KR101077461B1 (no) |
| AU (1) | AU2004211936B2 (no) |
| BR (1) | BRPI0407400A (no) |
| CA (1) | CA2515631C (no) |
| MX (1) | MXPA05008431A (no) |
| NO (1) | NO334659B1 (no) |
| NZ (1) | NZ541352A (no) |
| PL (1) | PL209130B1 (no) |
| RU (1) | RU2336081C2 (no) |
| WO (1) | WO2004071428A2 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7855226B2 (en) | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| JP2008518013A (ja) * | 2004-10-26 | 2008-05-29 | アラーガン、インコーポレイテッド | プロスタグランジンｅｐ４アゴニストによる処置方法およびデリバリー方法 |
| AU2012200514B2 (en) * | 2005-03-17 | 2014-03-06 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| WO2008041054A1 (en) * | 2006-10-02 | 2008-04-10 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates |
| CN105566192B (zh) * | 2006-10-02 | 2019-01-22 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药 |
| US8455547B2 (en) * | 2008-02-05 | 2013-06-04 | Allergan, Inc. | Substituted cyclopentanes having prostaglandin activity |
| US7732443B2 (en) * | 2008-03-18 | 2010-06-08 | Yariv Donde | Therapeutic substituted cyclopentanes |
| AU2009244541B2 (en) * | 2008-05-09 | 2014-01-09 | Allergan, Inc. | Therapeutic compounds |
| JP2013508282A (ja) | 2009-10-14 | 2013-03-07 | ジェンムス ファーマ インコーポレイティド | ウイルス感染のための併用療法処置 |
| US20120136011A1 (en) * | 2010-07-30 | 2012-05-31 | Allergan, Inc. | Compounds and methods for skin repair |
| US20120046332A1 (en) * | 2010-08-17 | 2012-02-23 | Allergan, Inc. | Compositions and methods for treating corneal haze |
| EP3884935B1 (en) | 2013-08-09 | 2023-06-14 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4117014A (en) * | 1976-01-09 | 1978-09-26 | Abbott Laboratories | Prostaglandin derivatives |
| JPS59101458A (ja) * | 1982-12-01 | 1984-06-12 | Nippon Iyakuhin Kogyo Kk | 新規なチアプロスタグランジン誘導体及びその製法 |
| JPS632972A (ja) * | 1986-06-20 | 1988-01-07 | Nippon Iyakuhin Kogyo Kk | 新規プロスタグランジンｅ↓１誘導体及びその製法 |
| US5462968A (en) * | 1994-01-19 | 1995-10-31 | Allergan, Inc. | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US5877211A (en) * | 1997-11-21 | 1999-03-02 | Allergan | EP2 receptor agonists as neuroprotective agents for the eye |
| US6410591B1 (en) * | 2001-05-08 | 2002-06-25 | Allergan Sales, Inc. | 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| US6531504B2 (en) * | 2001-05-17 | 2003-03-11 | Allergan, Inc. | Prostanoic acid derivatives as agents for lowering intraocular pressure |
| CA2450466C (en) * | 2001-06-14 | 2011-07-05 | Allergan, Inc. | 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
-
2004
- 2004-02-06 WO PCT/US2004/003433 patent/WO2004071428A2/en active Application Filing
- 2004-02-06 KR KR1020057014697A patent/KR101077461B1/ko active IP Right Grant
- 2004-02-06 EP EP04709028A patent/EP1608309B1/en not_active Expired - Lifetime
- 2004-02-06 AU AU2004211936A patent/AU2004211936B2/en not_active Ceased
- 2004-02-06 JP JP2006503371A patent/JP5319065B2/ja not_active Expired - Lifetime
- 2004-02-06 CA CA2515631A patent/CA2515631C/en not_active Expired - Fee Related
- 2004-02-06 BR BRPI0407400-9A patent/BRPI0407400A/pt not_active Application Discontinuation
- 2004-02-06 MX MXPA05008431A patent/MXPA05008431A/es active IP Right Grant
- 2004-02-06 PL PL378421A patent/PL209130B1/pl unknown
- 2004-02-06 RU RU2005129072/04A patent/RU2336081C2/ru active
- 2004-02-06 NZ NZ541352A patent/NZ541352A/en not_active IP Right Cessation
-
2005
- 2005-08-01 NO NO20053715A patent/NO334659B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05008431A (es) | 2005-10-19 |
| NO20053715D0 (no) | 2005-08-01 |
| CA2515631C (en) | 2013-08-20 |
| JP5319065B2 (ja) | 2013-10-16 |
| KR101077461B1 (ko) | 2011-10-26 |
| WO2004071428A2 (en) | 2004-08-26 |
| AU2004211936B2 (en) | 2008-09-11 |
| RU2005129072A (ru) | 2006-02-27 |
| EP1608309B1 (en) | 2012-07-11 |
| KR20050101202A (ko) | 2005-10-20 |
| AU2004211936A1 (en) | 2004-08-26 |
| PL378421A1 (pl) | 2006-04-03 |
| NZ541352A (en) | 2007-12-21 |
| JP2006517587A (ja) | 2006-07-27 |
| EP1608309A2 (en) | 2005-12-28 |
| NO334659B1 (no) | 2014-05-12 |
| PL209130B1 (pl) | 2011-07-29 |
| RU2336081C2 (ru) | 2008-10-20 |
| CA2515631A1 (en) | 2004-08-26 |
| BRPI0407400A (pt) | 2006-02-21 |
| WO2004071428A3 (en) | 2005-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053715L (no) | 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk | |
| ES2399314T3 (es) | Gamma lactamas sustituidas como agentes terapeúticos | |
| CY1113138T1 (el) | Παραγωγα 10,10-διαλκυλ προστανοϊκου οξεος ως παραγοντες για μειωση ενδο-οφθαλμικης πιεσης | |
| EA200500814A1 (ru) | Производные пирролопиримидина | |
| AR044543A1 (es) | Derivados de pirazolo-quinazolina, un procedimiento para su preparacion y su uso como inhibidor de quinasa | |
| SG159380A1 (en) | Heteroaryl compounds useful as inhibitors of gsk-3 | |
| UY26754A1 (es) | Derivados de la 1, 3, 8, -triaza-spiro (4,5) decan-4-ona | |
| RU2004132204A (ru) | Имидазоконденсированные соединения | |
| AR036044A1 (es) | Compuestos piranoindazoles, composiciones farmaceuticas y su uso para la manufactura de un medicamento para el tratamiento del glaucoma | |
| AR038864A1 (es) | Inhibidores pirimidina y piridina biciclicos de la p38 quinasa | |
| SE0302760D0 (sv) | New compounds | |
| AR058347A1 (es) | Entidades quimias composiciones y metodos | |
| WO2002089813A3 (en) | 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure | |
| CY1106335T1 (el) | Υποκατεστημενα παραγωγα 4-φαινυλ-4[1η-ιμιδαζολ-2-υλ]-πιπepιδινης για τη μειωση της ισχαιμικης βλαβης | |
| NO20051282L (no) | Antitumorale analoger av lamellariner. | |
| DK0437030T3 (da) | Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk | |
| MXPA04006033A (es) | Dicetopiperacinas sustituidas como antagonistas de oxitocina. | |
| DK1395263T3 (da) | 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk | |
| RU2374228C2 (ru) | Производные 4-фенилпиперидина в качестве ингибиторов ренина | |
| RU2009128968A (ru) | Производные изосорбидмононитрата для лечения повышенной внутриглазной гипертензии | |
| DE69824450D1 (de) | Biphenylamidin-derivate | |
| DK1390036T3 (da) | Prostansyrederivater som midler til nedsættelse af intraokulært tryk | |
| WO2005005394A3 (en) | Thiophenylaminoimidazolines as prostaglandin i2 antagonists | |
| ATE308540T1 (de) | Antithrombosemittel | |
| ES2452026T3 (es) | Prostaglandinas y análogos como agentes para disminuir la presión intraocular |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |